|
03.07.25 - 10:33
|
HUTCHMED to Announce 2025 Half-Year Financial Results (GlobeNewswire EN)
|
|
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 03, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2025 on Thursday, August 7, 2025 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT)....
|
|
03.07.25 - 06:30
|
Midday Takeaway: HSI Closes Midday at 23,989, Down 232 pts; HSTI Closes Midday at 5,205, Down 63 pts; XIAOMI Down over 4%; BABA Down over 3%; HENDERSON LAND, XINYI ENERGY, ASCENTAGE, GLOBAL NEW MAT, GREAT EAGLE H Hit New Highs (AAStocks)
|
|
At midday close, HSI dropped 232 pts or 1.0% to 23,989. HSTI dropped 63 pts or 1.2% to 5,205. HSCEI fell 108 pts or 1.2% to 8,616.Active Heavyweights:XIAOMI (01810.HK) closed at $57.5, down 4.4%BABA (09988.HK) closed at $105.5, down 3.6%MEITUAN (03690.HK) closed at $122.9, down 2.5%HKEX (00388.HK) closed at $417.6, down 1.3%TENC......
|
|
|
|
|
|
|
|
|
23.06.25 - 10:15
|
Full-day Takeaway: HSI Closes at 23,689, Up 158 pts; HSTI Closes at 5,187, Up 53 pts; BEIGENE Up over 6%; CCB, LINK REIT, ABC, BOC HONG KONG, ICBC Hit New Highs; Market Turnover Rises (AAStocks)
|
|
At close, HSI rose 158 pts or 0.7% to 23,689. HSTI rose 53 pts or 1.0% to 5,187. HSCEI gained 70 pts or 0.8% to 8,597. Market turnover reached $198.59 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $131.4, up 2.2%HKEX (00388.HK) closed at $399, up 1.6%XIAOMI (01810.HK) closed at $54.85, up 1.5%CCB (00939.HK) closed at ......
|
|
|
|
|
18.06.25 - 06:15
|
Midday Takeaway: HSI Down 281 pts; HSTI Down 83 pts; MEITUAN Down over 3%; UNITEDENERGY GP, ASCENTAGE, FORTUNE REIT, GUANGDONG INV Hit New Highs (AAStocks)
|
|
At midday close, HSI dropped 281 pts or 1.2% to 23,698. HSTI dropped 83 pts or 1.6% to 5,208. HSCEI fell 102 pts or 1.2% to 8,592.Active Heavyweights:MEITUAN (03690.HK) closed at $133, down 3.7%BABA (09988.HK) closed at $111.9, down 2.5%HKEX (00388.HK) closed at $404.6, down 2.1%PING AN (02318.HK) closed at $46.95, down 1.8%TENC......
|
|
|
17.06.25 - 12:45
|
HKD713.6M Southbound Trading Net Outflow from TENCENT (AAStocks)
|
|
There was HKD599.4 million, HKD271.2 million and HKD220.8 million Southbound Trading net inflow to BABA-W (09988.HK), POP MART (09992.HK) and XIAOMI-W (01810.HK).There was HKD713.6 million and HKD617.7 million Southbound Trading net outflow from TENCENT (00700.HK) and CSPC PHARMA (01093.HK).For Southbound Trading of Shanghai-Hon......
|
|
|
16.06.25 - 15:30
|
Teva, Shanghai Fosun Partner To Develop TEV-56278 (AFX)
|
|
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Monday said that they have partnered to develop TEV-56278.Teva's TEV-56278 ut......
|
|
|
16.06.25 - 13:06
|
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6 (GlobeNewswire EN)
|
|
BELTSVILLE, Md. and SHANGHAI, June 16, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, and Simcere Zaiming, an oncology-focused biopharmaceutical company and a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096), today announced a strategic partnership to develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. SIM0505 is currently in Phase 1 clinical testing in China; NextCure expects to begin clinical testing in the U.S. in the third quarter of 2025....
|
|